A look into Akebia Therapeutics Inc (AKBA)’s deeper side
With 3.6 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.43 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $3.62 whereas the lowest price it dropped to was $3.48. The […]
This trade activity should not be overlooked: Akebia Therapeutics Inc (AKBA)
With 3.98 million shares changed hands, the volume of the stock remained lighter than its average volume of 5.43 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $3.59 whereas the lowest price it dropped to was $3.46. The […]
A History of Outperforming Analyst Forecasts and Beating the Odds: Akebia Therapeutics Inc (AKBA)
With 6.95 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.57 million shares. The 52-week range on AKBA shows that it touched its highest point at $4.08 and its lowest point at $0.80 during that stretch. It currently has a 1-year price target of $7.40. Beta for […]
A History of Outperforming Analyst Forecasts and Beating the Odds: Akebia Therapeutics Inc (AKBA)
With 10.83 million shares changed hands, the volume of the stock remained heavier than its average volume of 5.44 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $3.925 whereas the lowest price it dropped to was $3.48. The […]
Nothing is Better Than Akebia Therapeutics Inc (AKBA) stock at the moment
With 7.16 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.96 million shares. The 52-week range on AKBA shows that it touched its highest point at $3.26 and its lowest point at $0.80 during that stretch. It currently has a 1-year price target of $7.30. Beta for […]
You might want to take a look at Akebia Therapeutics Inc (AKBA) now
With 3.54 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.8 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $2.96 whereas the lowest price it dropped to was $2.87. The […]
Healthy Upside Potential: Akebia Therapeutics Inc (AKBA)
With 6.74 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.62 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.90 and its lowest point at $0.80 during that stretch. It currently has a 1-year price target of $7.30. Beta for […]
Akebia Therapeutics Inc (AKBA) Clearly Signals Buy-Into the Stock: Don’t ignore the signals
With 7.03 million shares changed hands, the volume of the stock remained heavier than its average volume of 4.27 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.90 and its lowest point at $0.80 during that stretch. It currently has a 1-year price target of $7.30. Beta for […]
Nothing is Better Than Akebia Therapeutics Inc (AKBA) stock at the moment
With 3.87 million shares changed hands, the volume of the stock remained lighter than its average volume of 4.05 million shares. The 52-week range on AKBA shows that it touched its highest point at $2.89 and its lowest point at $0.80 during that stretch. It currently has a 1-year price target of $7.30. Beta for […]
Investors in cash trouble should check out Akebia Therapeutics Inc (AKBA)
With 2.82 million shares changed hands, the volume of the stock remained lighter than its average volume of 3.95 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $2.48 whereas the lowest price it dropped to was $2.3708. The […]
